203 related articles for article (PubMed ID: 3264193)
1. Aurin tricarboxylic acid: a novel inhibitor of the association of von Willebrand factor and platelets.
Phillips MD; Moake JL; Nolasco L; Turner N
Blood; 1988 Dec; 72(6):1898-903. PubMed ID: 3264193
[TBL] [Abstract][Full Text] [Related]
2. Isolation from commercial aurintricarboxylic acid of the most effective polymeric inhibitors of von Willebrand factor interaction with platelet glycoprotein Ib. Comparison with other polyanionic and polyaromatic polymers.
Weinstein M; Vosburgh E; Phillips M; Turner N; Chute-Rose L; Moake J
Blood; 1991 Nov; 78(9):2291-8. PubMed ID: 1932745
[TBL] [Abstract][Full Text] [Related]
3. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets.
Alevriadou BR; Moake JL; Turner NA; Ruggeri ZM; Folie BJ; Phillips MD; Schreiber AB; Hrinda ME; McIntire LV
Blood; 1993 Mar; 81(5):1263-76. PubMed ID: 8443388
[TBL] [Abstract][Full Text] [Related]
4. Unexpected effects of aurin tricarboxylic acid on human platelets.
Kinlough-Rathbone RL; Packham MA
Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
[TBL] [Abstract][Full Text] [Related]
5. Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein Ib.
Girma JP; Fressinaud E; Christophe O; Rouault C; Obert B; Takahashi Y; Meyer D
Thromb Haemost; 1992 Dec; 68(6):707-13. PubMed ID: 1287886
[TBL] [Abstract][Full Text] [Related]
6. The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis.
Azzam K; Cissé-Thiam M; Drouet L
Thromb Haemost; 1996 Jan; 75(1):203-10. PubMed ID: 8713802
[TBL] [Abstract][Full Text] [Related]
7. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation.
Chow TW; Hellums JD; Moake JL; Kroll MH
Blood; 1992 Jul; 80(1):113-20. PubMed ID: 1611079
[TBL] [Abstract][Full Text] [Related]
8. A new binding assay of von Willebrand factor and glycoprotein Ib using solid-phase biotinylated platelets.
Hayata K; Nakayama T; Matsushita T; Sakano K
J Pharmacol Sci; 2008 Oct; 108(2):217-21. PubMed ID: 18845909
[TBL] [Abstract][Full Text] [Related]
9. M(r) 6,400 aurin tricarboxylic acid directly activates platelets.
Guo Z; Weinstein MJ; Phillips MD; Kroll MH
Thromb Res; 1993 Jul; 71(1):77-88. PubMed ID: 8367837
[TBL] [Abstract][Full Text] [Related]
10. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin.
Moake JL; Turner NA; Stathopoulos NA; Nolasco L; Hellums JD
Blood; 1988 May; 71(5):1366-74. PubMed ID: 3258770
[TBL] [Abstract][Full Text] [Related]
11. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers.
Weiss HJ; Sussman II
Blood; 1986 Jul; 68(1):149-56. PubMed ID: 3487353
[TBL] [Abstract][Full Text] [Related]
12. A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction, and the presence of all von Willebrand factor multimers in plasma.
Casonato A; De Marco L; Mazzucato M; De Angelis V; De Roia D; Fabris F; Ruggeri ZM; Girolami A
Blood; 1989 Nov; 74(6):2028-33. PubMed ID: 2804346
[TBL] [Abstract][Full Text] [Related]
13. Platelet-collagen interaction: inhibition by ristocetin and enhancement by von Willebrand factor-platelet binding.
LaDuca FM; Bettigole RE; Bell WR; Robson EB
Blood; 1986 Oct; 68(4):927-37. PubMed ID: 3489493
[TBL] [Abstract][Full Text] [Related]
14. Aurin tricarboxylic acid inhibits adhesion of platelets to subendothelium.
Owens MR; Holme S
Thromb Res; 1996 Jan; 81(2):177-85. PubMed ID: 8822132
[TBL] [Abstract][Full Text] [Related]
15. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.
Moake JL; Turner NA; Stathopoulos NA; Nolasco LH; Hellums JD
J Clin Invest; 1986 Dec; 78(6):1456-61. PubMed ID: 3491092
[TBL] [Abstract][Full Text] [Related]
16. Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers.
Gjønnaess E; Solum NO; Brosstad F
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):395-405. PubMed ID: 1420815
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
Zucker MB; Puszkin EG; Sussman II; Mauss EA
J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846
[TBL] [Abstract][Full Text] [Related]
18. Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa.
De Marco L; Mazzucato M; De Roia D; Casonato A; Federici AB; Girolami A; Ruggeri ZM
J Clin Invest; 1990 Sep; 86(3):785-92. PubMed ID: 2394830
[TBL] [Abstract][Full Text] [Related]
19. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
Moore JC; Murphy WG; Kelton JG
Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
[TBL] [Abstract][Full Text] [Related]
20. von Willebrand factor. A protein which binds at the cell surface interface between platelets.
Senogles SE; Nelsestuen GL
J Biol Chem; 1983 Oct; 258(20):12327-33. PubMed ID: 6605342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
